NasdaqGM - Nasdaq Real Time Price USD
Silexion Therapeutics Corp (SLXN)
At close: 4:00 PM EST
After hours: 6:11 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
Operating Expense
12,399.0000
4,681.0000
3,860.0000
Operating Income
-12,399.0000
-4,681.0000
-3,860.0000
Net Non Operating Interest Income Expense
-4,739.0000
144.0000
29.0000
Other Income Expense
701.0000
-539.0000
367.0000
Pretax Income
-16,437.0000
-5,076.0000
-3,464.0000
Tax Provision
15.0000
32.0000
24.0000
Net Income Common Stockholders
-16,424.0000
-4,942.0000
-3,215.0000
Diluted NI Available to Com Stockholders
-16,424.0000
-4,942.0000
-3,215.0000
Basic EPS
-1.47
-0.61
-0.39
Diluted EPS
-1.47
-0.61
-0.39
Basic Average Shares
11,180.0310
8,151.6500
8,151.6500
Diluted Average Shares
11,180.0310
8,151.6500
8,151.6500
Total Operating Income as Reported
-12,399.0000
-4,681.0000
-3,860.0000
Rent Expense Supplemental
109.0000
86.0000
71.0000
Total Expenses
12,399.0000
4,681.0000
3,860.0000
Net Income from Continuing & Discontinued Operation
-16,424.0000
-4,942.0000
-3,215.0000
Normalized Income
-16,963.7700
-4,526.9700
-3,497.5900
Interest Income
58.0000
153.0000
114.0000
Net Interest Income
-4,739.0000
144.0000
29.0000
EBIT
-12,399.0000
-4,681.0000
-3,860.0000
EBITDA
-12,356.0000
-4,636.0000
-3,803.0000
Reconciled Depreciation
43.0000
45.0000
57.0000
Net Income from Continuing Operation Net Minority Interest
-16,424.0000
-4,942.0000
-3,215.0000
Total Unusual Items Excluding Goodwill
701.0000
-539.0000
367.0000
Total Unusual Items
701.0000
-539.0000
367.0000
Normalized EBITDA
-13,057.0000
-4,097.0000
-4,170.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
161.2300
-123.9700
84.4100
12/31/2022 - 4/7/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CDT Conduit Pharmaceuticals Inc.
0.1040
-3.61%
APLM Apollomics, Inc.
0.0918
-9.11%
HOTH Hoth Therapeutics, Inc.
0.8400
+1.11%
TVGN Tevogen Bio Holdings Inc.
1.5000
-8.54%
MTEM Molecular Templates, Inc.
0.3353
-8.39%
TFFP TFF Pharmaceuticals, Inc.
0.3402
-2.91%
CERO CERo Therapeutics Holdings, Inc.
0.2181
-12.02%
TNXP Tonix Pharmaceuticals Holding Corp.
0.1900
-6.95%
XCUR Exicure, Inc.
18.38
+69.24%
FBRX Forte Biosciences, Inc.
16.00
+2.30%